Robert W. Duggan, Co-CEO: Summit Therapeutics SMMT Buy · Filed 06/12

Trade details

Type: Insider buy
Amount: $49,987,200
Shares · price: 3,810,000 sh · $13.12 a share
Held after: 573,883,879 sh
Stock: Summit Therapeutics SMMT
Person: Robert W. DugganCo-CEO
Trade date: 26/06/12
Filed: 26/06/12
Days to filing: 0 days

First buy since 2023

Insiders buying this week: 2 insiders
Holding change: +0.7%

Summit Therapeutics trades, last 26 weeks

What else happened in Summit Therapeutics around then

Filed or reported within 30 days of the trade day · 05/13~07/12

Robert W. Duggan's recent trades

Robert W. DugganCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$1.5M
100,000 sh
$1.5M
Filed 06/04
Traded 06/04
Robert W. DugganDirector
BuyPulse Biosciences
Buy
Pulse Biosciences
PLSE
$13M
660,233 sh
$13M
Filed 05/15
Traded 05/11
Robert W. DugganDirector
BuyPulse Biosciences
Buy
Pulse Biosciences
PLSE
$13M
660,233 sh
$13M
Filed 05/11
Traded 05/11
Robert W. DugganCo-CEO
BuySummit Therapeutics
Buy
Summit Therapeutics
SMMT
$500K
26,680 sh
$500K
Filed 25/10/23
Traded 25/10/21
Robert W. DugganDirector
BuyPulse Biosciences
Buy
Pulse Biosciences
PLSE
$2.1M
145,140 sh
$2.1M
Filed 25/09/12
Traded 24/09/12